07.2020: Financial investor capiton takes over CNP Group, based in Germany. CNP is an international manufacturer and distributor of generic pharmaceuticals with a focus on anti-infectives. In addition to antibiotics, CNP offers over-the-counter medicines and medical devices. Most of the products are manufactured at the company’s two production sites in Saarland, Germany. CNP owns marketing authorizations for approx. 400 pharmaceutical products and generates revenues of more than € 40 million with approx. 250 employees. The group is active in 19 countries.
In cooperation with the management team and supported by industry experts, capiton plans to leverage the company’s substantial local production capacity and international footprint to further strengthen CNP´s leading position in target niche markets. CNP Group has been acquired from the founding family and additional funds have been reserved to finance both organic and inorganic growth initiatives in Germany and abroad.
The transaction remains subject to approval from competition authorities.